anmelden
BioCryst Pharmaceuticals Aktie
7,87
EUR
+0,09
EUR
+1,13
%
8,98
USD
+0,04
USD
+0,39
%
BioCryst Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
BioCryst Pharmaceuticals Aktie Analyse
| 22.06.18 | BioCryst Pharmaceuticals Neutral | Seaport Global Securities | |
| 20.12.17 | BioCryst Pharmaceuticals Equal weight | Barclays Capital | |
| 15.09.17 | BioCryst Pharmaceuticals Sector Perform | RBC Capital Markets | |
| 12.11.07 | BioCryst Pharmaceuticals average | Caris & Company, Inc. | |
| 20.09.07 | BioCryst Pharmaceuticals average | Caris & Company, Inc. | |
| 29.08.07 | BioCryst Pharmaceuticals halten | Jaindl & Mautz | |
| 20.06.07 | BioCryst Pharmaceuticals average | Caris & Company | |
| 29.03.07 | BioCryst Pharmaceuticals market perform | CE Unterberg, Towbin | |
|
Werbung
|
|||
| 19.02.07 | BioCryst Pharmaceuticals neutral | Jaindl & Mautz | |
| 11.12.06 | BioCryst Pharmaceuticals Average | Caris & Company | |
| 14.11.06 | BioCryst Pharmaceuticals halten | Jaindl & Mautz | |
| 11.10.06 | BioCryst Pharmaceuticals halten | Jaindl & Mautz | |
| 28.04.06 | BioCryst Pharmaceuticals Market Perform | CE Unterberg, Towbin | |
| 20.04.06 | BioCryst Pharmaceuticals | Caris & Company | |
| 27.10.05 | BioCryst Pharmaceuticals Market Perform | Rodman & Renshaw | |
Werbung
Werbung